Differences in buprenorphine prescribing readiness among primary care professionals with and without X-waiver training in the US

Table 2 Regression coefficients for the relationship between receipt of X-waiver and primary outcomes (n = 403)

	Likelihood of believing buprenorphine is effective			Likelihood of believing buprenorphine helps people enter remission			Training			Predicting buprenorphine knowledge
	Coef.	SE	95% CI	Coef.	SE	95% CI	Coef.	SE	95% CI	OR	SE	95% CI
Unadjusted
X-waiver	0.66^±±	.09	0.49, 0.84	0.47^±±	0.10	0.28–0.67	1.21^±±	0.11	0.99, 1.44	2.61^±±	0.54	1.75, 3.90
Adjusted
X-waiver	0.66^±±	0.09	0.47, 0.84	0.48^±±	0.10	0.28, 0.68	1.18^±±	0.12	0.94, 1.42	2.75^±±	0.60	1.79, 4.22
Female	-0.18	0.11	− 0.39, 0.03	0.15	0.11	− 0.08, 0.37	− 0.25	0.14	− 0.52, 0.03	1.04	0.26	0.64, 1.70
Age	− 0.00	0.00	− 0.01, 0.01	− 0.01	0.00	− 0.02, 0.00	0.00	0.00	− 0.01, 0.02	0.99	0.01	0.97, 1.01
Work hours	0.01*	0.00	0.00, 0.01	0.00	0.00	− 0.00, 0.01	0.00	1.16	− 0.01, 0.01	1.01	0.01	0.99, 1.03
Years in job	0.00	0.00	− 0.00, 0.01	− 0.00	0.00	− 0.01, 0.01	0.00	0.01	− 0.01, 0.01	0.99	0.01	0.97, 1.01
Physician assistant	− 0.13	0.12	− 0.37, 0.12	− 0.19	0.13	− 0.45, 0.08	0.23	0.16	− 0.09, 0.56	0.49*	0.14	0.28, 0.87
Nurse practitioner	0.15	0.13	− 0.10, 0.40	− 0.32*	0.14	− 0.59, − 0.05	− 0.13	0.17	− 0.46, 0.20	0.56	0.17	0.31, 1.01
Physician	REF	REF	REF	REF	REF	REF	REF	REF	REF	REF	REF	REF
Family medicine	− 0.03	0.11	− 0.24, 0.18	0.06	0.12	− 0.17, 0.28	0.21	0.14	− 0.07, 0.49	0.79	0.20	0.48, 1.31

^*p < .05; ^±p < .01; and ^±±p < .001
REF Reference group, Coef. Coefficient, OR Odds ratio, SE Standard error, and CI Confidence interval

ISSN: 1477-7517